It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA — and the agency circled a date for the adcomm

Nicole DeFeudis

Editor

Pfizer and BioNTech’s request for emergency authorization of its Covid-19 vaccine is now in the FDA’s hands. Regulators caught the application Friday afternoon in an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA — and the agency circled a date for the adcomm

Nicole DeFeudis

Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

It's of­fi­cial: Pfiz­er and BioN­Tech have sub­mit­ted their Covid-19 vac­cine to the FDA — and the agency cir­cled a date for the ad­comm

Editor

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

It's official: Pfizer and BioNTech have submitted their Covid-19 vaccine to the FDA — and the agency circled a date for the adcomm